BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 33179249)

  • 1. Description of neurodevelopmental phenotypes associated with 10 genetic neurodevelopmental disorders: A scoping review.
    Hanly C; Shah H; Au PYB; Murias K
    Clin Genet; 2021 Mar; 99(3):335-346. PubMed ID: 33179249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders.
    Choi SA; Lee HS; Park TJ; Park S; Ko YJ; Kim SY; Lim BC; Kim KJ; Chae JH
    Brain Dev; 2021 Oct; 43(9):912-918. PubMed ID: 34116881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders.
    Kilinc M; Creson T; Rojas C; Aceti M; Ellegood J; Vaissiere T; Lerch JP; Rumbaugh G
    Mol Cell Neurosci; 2018 Sep; 91():140-150. PubMed ID: 29580901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commonalities and distinctions between two neurodevelopmental disorder subtypes associated with SCN2A and SCN8A variants and literature review.
    Mangano GD; Fontana A; Antona V; Salpietro V; Mangano GR; Giuffrè M; Nardello R
    Mol Genet Genomic Med; 2022 May; 10(5):e1911. PubMed ID: 35348308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.
    Srivastava S; Love-Nichols JA; Dies KA; Ledbetter DH; Martin CL; Chung WK; Firth HV; Frazier T; Hansen RL; Prock L; Brunner H; Hoang N; Scherer SW; Sahin M; Miller DT;
    Genet Med; 2019 Nov; 21(11):2413-2421. PubMed ID: 31182824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in Understanding and Treating SCN2A-Mediated Disorders.
    Sanders SJ; Campbell AJ; Cottrell JR; Moller RS; Wagner FF; Auldridge AL; Bernier RA; Catterall WA; Chung WK; Empfield JR; George AL; Hipp JF; Khwaja O; Kiskinis E; Lal D; Malhotra D; Millichap JJ; Otis TS; Petrou S; Pitt G; Schust LF; Taylor CM; Tjernagel J; Spiro JE; Bender KJ
    Trends Neurosci; 2018 Jul; 41(7):442-456. PubMed ID: 29691040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Counseling in Neurodevelopmental Disorders.
    Blesson A; Cohen JS
    Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31501260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of early neurodevelopmental features of children with SYNGAP1 variants and their genotypes].
    Liu H; Yang S; Li J; Xie H; Chen X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jan; 41(1):25-31. PubMed ID: 38171555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characterization of Copy Number Variants Associated With Neurodevelopmental Disorders in a Large-scale Multiancestry Biobank.
    Birnbaum R; Mahjani B; Loos RJF; Sharp AJ
    JAMA Psychiatry; 2022 Mar; 79(3):250-259. PubMed ID: 35080590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression.
    Jimenez-Gomez A; Niu S; Andujar-Perez F; McQuade EA; Balasa A; Huss D; Coorg R; Quach M; Vinson S; Risen S; Holder JL
    J Neurodev Disord; 2019 Aug; 11(1):18. PubMed ID: 31395010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants.
    Hamanaka K; Miyake N; Mizuguchi T; Miyatake S; Uchiyama Y; Tsuchida N; Sekiguchi F; Mitsuhashi S; Tsurusaki Y; Nakashima M; Saitsu H; Yamada K; Sakamoto M; Fukuda H; Ohori S; Saida K; Itai T; Azuma Y; Koshimizu E; Fujita A; Erturk B; Hiraki Y; Ch'ng GS; Kato M; Okamoto N; Takata A; Matsumoto N
    Genome Med; 2022 Apr; 14(1):40. PubMed ID: 35468861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP.
    Van Dijck A; Vulto-van Silfhout AT; Cappuyns E; van der Werf IM; Mancini GM; Tzschach A; Bernier R; Gozes I; Eichler EE; Romano C; Lindstrand A; Nordgren A; ; Kvarnung M; Kleefstra T; de Vries BBA; Küry S; Rosenfeld JA; Meuwissen ME; Vandeweyer G; Kooy RF
    Biol Psychiatry; 2019 Feb; 85(4):287-297. PubMed ID: 29724491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the genetic basis of comorbid epilepsy phenotypes in neurodevelopmental disorders.
    Chow J; Jensen M; Amini H; Hormozdiari F; Penn O; Shifman S; Girirajan S; Hormozdiari F
    Genome Med; 2019 Oct; 11(1):65. PubMed ID: 31653223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and phenotypic findings in 34 novel Spanish patients with DDX3X neurodevelopmental disorder.
    Parra A; Pascual P; Cazalla M; Arias P; Gallego-Zazo N; San-Martín EA; Silván C; Santos-Simarro F; ; Nevado J; Tenorio-Castano J; Lapunzina P
    Clin Genet; 2024 Feb; 105(2):140-149. PubMed ID: 37904618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct genetic patterns of shared and unique genes across four neurodevelopmental disorders.
    Zhang Y; Wang R; Liu Z; Jiang S; Du L; Qiu K; Li F; Wang Q; Jin J; Chen X; Li Z; Wu J; Zhang N
    Am J Med Genet B Neuropsychiatr Genet; 2021 Jan; 186(1):3-15. PubMed ID: 32929885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of the Maternal and Child Health Handbook in Early Identification of Autism Spectrum Disorder and Other Neurodevelopmental Disorders.
    Hirota T; Bishop S; Adachi M; Shui A; Takahashi M; Mori H; Nakamura K
    Autism Res; 2021 Mar; 14(3):551-559. PubMed ID: 33251760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic missense mutation pattern of forkhead box genes in neurodevelopmental disorders.
    Han L; Chen M; Wang Y; Wu H; Quan Y; Bai T; Li K; Duan G; Gao Y; Hu Z; Xia K; Guo H
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00789. PubMed ID: 31199603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing Sensory Phenotypes of Subgroups with a Known Genetic Etiology Pertaining to Diagnoses of Autism Spectrum Disorder and Intellectual Disability.
    Hudac CM; Friedman NR; Ward VR; Estreicher RE; Dorsey GC; Bernier RA; Kurtz-Nelson EC; Earl RK; Eichler EE; Neuhaus E
    J Autism Dev Disord; 2024 Jun; 54(6):2386-2401. PubMed ID: 37031308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome.
    Bend EG; Aref-Eshghi E; Everman DB; Rogers RC; Cathey SS; Prijoles EJ; Lyons MJ; Davis H; Clarkson K; Gripp KW; Li D; Bhoj E; Zackai E; Mark P; Hakonarson H; Demmer LA; Levy MA; Kerkhof J; Stuart A; Rodenhiser D; Friez MJ; Stevenson RE; Schwartz CE; Sadikovic B
    Clin Epigenetics; 2019 Apr; 11(1):64. PubMed ID: 31029150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo mutation of cancer-related genes associates with particular neurodevelopmental disorders.
    Li B; Li K; Tian D; Zhou Q; Xie Y; Fang Z; Wang X; Luo T; Wang Z; Zhang Y; Wang Y; Chen Q; Meng Q; Zhao G; Li J
    J Mol Med (Berl); 2020 Dec; 98(12):1701-1712. PubMed ID: 33047154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.